With New Reimbursement Models Emerging, Will Drug Prices Really Decrease?

The cost of prescription drugs continues to be a major concern for employers. Disruptors have emerged, coupled with bi-partisan and multistakeholder pressure, pushing new and existing players to make big moves. Will it truly be enough to rein in drug costs?